Satoshi Watanabe

Active 1968–2025

Also published as
Satoshi WATANABE
246
Papers
29,269
Citations
85
h-index
199
i10-index

Citations

Citations per year for Satoshi Watanabe1976: 1 citations1985: 1 citations1986: 1 citations1988: 3 citations1989: 3 citations1990: 2 citations1991: 1 citations1992: 3 citations1993: 2 citations1994: 1 citations1995: 5 citations1996: 5 citations1997: 10 citations1998: 6 citations1999: 15 citations2000: 18 citations2001: 16 citations2002: 23 citations2003: 17 citations2004: 23 citations2005: 27 citations2006: 48 citations2007: 51 citations2008: 82 citations2009: 116 citations2010: 94 citations2011: 132 citations2012: 138 citations2013: 153 citations2014: 147 citations2015: 154 citations2016: 135 citations2017: 168 citations2018: 193 citations2019: 566 citations2020: 962 citations2021: 1,103 citations2022: 854 citations2023: 718 citations2024: 1,100 citations2025: 543 citations2026: 18 citations1977–1984: no citations, so these years are not shown1987: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,428 citing papers, 21.3% of this breakdownChina: 1,670 citing papers, 14.7% of this breakdownJapan: 1,123 citing papers, 9.9% of this breakdownUnited Kingdom: 616 citing papers, 5.4% of this breakdownGermany: 580 citing papers, 5.1% of this breakdownItaly: 440 citing papers, 3.9% of this breakdownFrance: 405 citing papers, 3.5% of this breakdownCanada: 312 citing papers, 2.7% of this breakdownSouth Korea: 291 citing papers, 2.5% of this breakdownSpain: 257 citing papers, 2.3% of this breakdownAustralia: 250 citing papers, 2.2% of this breakdownNetherlands: 249 citing papers, 2.2% of this breakdown
0%21.3%Other 24.3%

Fields

  • Medicine41.6%
  • Biochemistry, Genetics and Molecular Biology23.3%
  • Agricultural and Biological Sciences6.9%
  • Neuroscience6.3%
  • Immunology and Microbiology5.8%
  • Environmental Science3.6%
  • Other12.5%

Topics

  • Lung Cancer Treatments and Mutations4.2%
  • Lung Cancer Research Studies2.4%
  • Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis2.3%
  • Immune cells in cancer1.8%
  • Neuroscience and Neuropharmacology Research1.6%
  • Cancer Immunotherapy and Biomarkers1.6%
  • Other86.1%

Coauthors

All papers

Open in search
  1. The role of macrophages in the resolution of inflammation

    Authors: , , , - Journal of Clinical Investigation 2019 cited by 903

  2. Single-Cell Transcriptomic Analysis of Human Lung Provides Insights into the Pathobiology of Pulmonary Fibrosis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Gökhan M. Mutlu, Anjana V. Yeldandi, Stacy A. Marshall, Ali Shilatifard, Luı́s A. Nunes Amaral, Harris Perlman, Jacob I. Sznajder, A. Christine Argento, Colin T. Gillespie, Jane E. Dematte, Manu Jain, Benjamin D. Singer, Karen M. Ridge, Anna P. Lam, Ankit Bharat, Sangeeta Bhorade, Cara J. Gottardi, G. R. Scott Budinger, Alexander V. Misharin - American Journal of Respiratory and Critical Care Medicine 2018 cited by 1,274

  3. A spatially restricted fibrotic niche in pulmonary fibrosis is sustained by M-CSF/M-CSFR signalling in monocyte-derived alveolar macrophages

    Authors: , , , , , , , , , , , , , , , , , , , , - European Respiratory Journal 2019 cited by 341

  4. Cysteinyl-tRNA synthetase governs cysteine polysulfidation and mitochondrial bioenergetics

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , - Nature Communications 2017 cited by 543

  5. AXL confers intrinsic resistance to osimertinib and advances the emergence of tolerant cells

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - Nature Communications 2019 cited by 363

  6. Ramucirumab plus erlotinib in patients with untreated, EGFR-mutated, advanced non-small-cell lung cancer (RELAY): a randomised, double-blind, placebo-controlled, phase 3 trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Walburga Engel-Riedel, Stefan Hammerschmidt, Wolfgang Schütte, Konstantinos Syrigos, Jcm Ho, Kwok‐Hung Au, Silvia Novello, Andrea Ardizzoni, Giulia Pasello, Vanessa Gregorc, Alessandro Del Conte, Domenico Galetta, Toshiaki Takahashi, Kazuhiko Nakagawa, Makoto Nishio, Kiyotaka Yoh, Takashi Seto, Fumio Imamura, Toru Kumagai, Katsuyuki Hotta, Yasushi Goto, Yukio Hosomi, Hiroshi Sakai, Yuichi Takiguchi, Young Hak Kim, Takayasu Kurata, Hiroyuki Yamaguchi, Haruko Daga, Isamu Okamoto, Miyako Satouchi, Satoshi Ikeda, Kazuo Kasahara, Shinji Atagi, Koichi Azuma, Toru Kumagai, Keisuke Aoe, Toru Kumagai, Keisuke Aoe, Yoshitsugu Horio, Nobuyuki Yamamoto, Hiroshi Tanaka, Satoshi Watanabe, Naoyuki Nogami, Tomohiro Ozaki, Ryo Koyama, Tomonori Hirashima, Hiroyasu Kaneda, Keisuke Tomii, Yuka Fujita, Masahiro Seike, Naoki Nishimura, Terufumi Kato, Masao Ichiki, Hideo Saka, Katsuya Hirano, Yasuharu Nakahara, Shunichi Sugawara, Keunchil Park, Sang‐We Kim, Young Joo Min, Hyun Woo Lee, Jin‐Hyoung Kang, Ho Jung An, Ki Hyeong Lee, Jin-Soo Kim, Gyeong‐Won Lee, Sung Yong Lee, Aurelia Alexandru, Anghel Adrian Udrea, Óscar Juan and 31 more - The Lancet Oncology 2019 cited by 613

  7. Erlotinib plus bevacizumab versus erlotinib alone in patients with EGFR-positive advanced non-squamous non-small-cell lung cancer (NEJ026): interim analysis of an open-label, randomised, multicentre, phase 3 trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , - The Lancet Oncology 2019 cited by 636

  8. Transplantation of intestinal organoids into a mouse model of colitis

    Authors: , , , , , , , - Nature Protocols 2022 cited by 137

  9. Alectinib versus crizotinib in patients with ALK -positive non-small-cell lung cancer (J-ALEX): an open-label, randomised phase 3 trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , - The Lancet 2017 cited by 912

  10. The lung microenvironment shapes a dysfunctional response of alveolar macrophages in aging

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , William E. Balch, Benjamin D. Singer, Alexander V. Misharin, G. R. Scott Budinger - Journal of Clinical Investigation 2021 cited by 177

  11. Global flood risk under climate change

    Authors: , , , , , , , - Nature Climate Change 2013 cited by 3,000

  12. Resetting proteostasis with ISRIB promotes epithelial differentiation to attenuate pulmonary fibrosis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2021 cited by 95

  13. Supersulphides provide airway protection in viral and chronic lung diseases

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Takaaki Akaike - Nature Communications 2023 cited by 61

  14. Structural dynamics of dendritic spines in memory and cognition

    Authors: , , , , - Trends in Neurosciences 2010 cited by 812

  15. Bevacizumab plus erlotinib versus erlotinib alone in Japanese patients with advanced, metastatic, EGFR-mutant non-small-cell lung cancer (NEJ026): overall survival analysis of an open-label, randomised, multicentre, phase 3 trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , - The Lancet Respiratory Medicine 2021 cited by 125

  16. ONO-7475, a Novel AXL Inhibitor, Suppresses the Adaptive Resistance to Initial EGFR-TKI Treatment in EGFR -Mutated Non–Small Cell Lung Cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , - Clinical Cancer Research 2020 cited by 113

  17. Observation of OH radicals produced by pulsed discharges on the surface of a liquid

    Authors: , , , , , , , , - Plasma Sources Science and Technology 2011 cited by 337

  18. Benchmark of 16S rRNA gene amplicon sequencing using Japanese gut microbiome data from the V1–V2 and V3–V4 primer sets

    Authors: , , , , , , , , , - BMC Genomics 2021 cited by 117

  19. Development of realistic high-resolution whole-body voxel models of Japanese adult males and females of average height and weight, and application of models to radio-frequency electromagnetic-field dosimetry

    Authors: , , , , , , - Physics in Medicine and Biology 2003 cited by 773

  20. Standardized volumetric plaque quantification and characterization from coronary CT angiography: a head-to-head comparison with invasive intravascular ultrasound

    Authors: , , , , , , , , , , , - European Radiology 2019 cited by 93

  21. Usefulness of Machine Learning-Based Gut Microbiome Analysis for Identifying Patients with Irritable Bowels Syndrome

    Authors: , , , , , , , , , , , , , , , , , - Journal of Clinical Medicine 2020 cited by 78

  22. Effect of Benralizumab on Mucus Plugs in Severe Eosinophilic Asthma

    Authors: , , , , , , , , , , , - International Archives of Allergy and Immunology 2023 cited by 48

  23. Final progression-free survival results from the J-ALEX study of alectinib versus crizotinib in ALK-positive non-small-cell lung cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , - Lung Cancer 2019 cited by 147

  24. Evaluation of Face2Gene using facial images of patients with congenital dysmorphic syndromes recruited in Japan

    Authors: , , , , , , , , , , - Journal of Human Genetics 2019 cited by 81